Dr. Mark H. Yudin, MD, MSc, FRCSC
Obstetrics, Gynecology, & Reproductive Infectious Diseases
St. Michael's Hospital, Toronto, Ontario
Dr. Robert Gagnon, MD FRCSC
Department of Obstetrics & Gynaecology, McGill University
Dr. Owen Hughes, MD, CFPC
Assistant Professor, University of Ottawa
Dr. Vyta Senikas, BSc MDCM, FRCSC, FSOGC, CSPQ, MBA
Associate Executive Vice-President
The Society of Obstetricians and Gynaecologists of Canada (SOGC)
Beginning November 18, 2009 and ending November 17, 2009
Learning Objectives
Appreciate the risks posed by H1N1 infection to pregnant women and the fetus
Identify the position of pregnant women in the Canadian and Provincial H1N1 vaccine priority lists
Identify the benefits and risks of H1N1 vaccination in pregnancy
Understand the differences between adjuvanted and unadjuvanted H1N1 vaccines for pregnant women
Review clinical management considerations regarding the timing and mode of delivery of pregnant women requiring hospitalization for H1N1 influenza-like-illness (ILI)
Discuss the role of antiviral agents in pregnant women with H1N1 infection
This online CME event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada. This program is recognized as 2 hour(s) of Continuing Professional Development.
This case study is free to all healthcare professionals.
AdvancingIn
ob/gyn specialist, family physician, midwife, nurse and pharmacist
Last Updated February 17, 2010
The Society of Obstetricians and Gynaecologists of Canada (SOGC)
780 Echo Drive Ottawa, ON K1S 5R7
Tel: (800) 561-2416 or (613) 730-4192 | Fax: (613) 730-4314 | E-mail: helpdesk@sogc.com
Copyright. All Rights Reserved. | Privacy Policy | Terms of Use